Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors
Considering the unrecognised physio-pathological role of human carbonic anhydrase III (hCA III), a structure-based drug design was set up to identify the first-in-class potent and selective inhibitors of this neglected isoform. hCA III targeting was planned considering a unique feature of its active...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2023-12-01
|
| Seri Bilgileri: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/14756366.2023.2202360 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|